Symbol
| SGPL1
| contributors: mct - updated : 23-05-2017
|
HGNC name
| sphingosine-1-phosphate lyase 1
|
HGNC id
| 10817
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in fibrotic lung tissues and primary lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis (IPF) | constitutional
|  
|  
|  
| loss of function
|
produces a pro-inflammatory response while impairing neutrophil trafficking | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | neurodegenerative | | |
autophagy modulators (as SGPL1) hold an enormous therapeutic potential in the treatment of neurodegenerative diseases |
| | | |
| Sgpl1-/- mice recapitulated the main characteristics of the human disease with abnormal adrenal and renal morphology | |
S1P lyase deficiency in mice causes a severe, lethal phenotype |
|
Sgpl1-deficient mice have low numbers of lymphocytes and high numbers of neutrophils in their blood |